Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on LinkedIn about a paper by Douglas Hanahan published in Cell:
“Hot off the press – A new chapter in cancer biology’s foundational text!
Hanahan’s ‘Hallmarks of Cancer—Then and Now, and Beyond’ drops in the journal CELL
—updating the framework that has shaped 25 years of oncology research, precision oncology and clinical trials
The roadmap evolves. Required reading.”
You can read the full article in the Cell.
More posts featuring Vivek Subbiah.